New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2013
12:09 EDTASTMAastrom downgraded to Sell from Neutral at Roth Capital
Roth Capital downgraded Aastrom to Sell with a 25c price target after the company said it will stop enrollment and end the Phase 3 REVIVE clinical trial in patients with critical limb ischemia.
News For ASTM From The Last 14 Days
Check below for free stories on ASTM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 22, 2014
09:04 EDTASTMAastrom reports treatment with Ixmyelocel-T reduces incidence of cardio events
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use